Skip to main content

Advertisement

Table 6 Causes of deviation from guidelines for every drug and diagnosis in %

From: Patient and physician related factors of adherence to evidence based guidelines in diabetes mellitus type 2, cardiovascular disease and prevention: a cross sectional study

Causes of deviation from guidelines from patient’s view
n 69 8 15 8 4 15 53 12 21
Reason (in %) Anti-HT Metformin HF: βB HF: RAAS-I HF: AldoA AF: OAK CVD: statin CVD: antipltlt MCI: βB
I don’t know 91.3 50.0 60.0 62.5 75.0 66.7 30.2 50.0 76.2
I don’t need it 2.9 25.0 26.7 37.5 25.0   45.3 25.0 9.5
I don’t want it   12.5     13.3 7.5   
Adverse drug event 4.3   13.3    6.7 7.5   4.8
Falsely discontinued 1.4 12.5     13.3 9.4 25.0 9.5
Causes of deviation from guidelines from physician’s view
n 69 8 15 8 4 15 53 12 21
Reason (in %) Anti-HT Metformin HF: βB HF: RAAS-I HF: AldoA AF: OAK CVD: statin CVD: PAI MCI: βB
Falsely not indicated GP 78.3 37.5 80.0 62.5 50.0 33.3 56.6 33.3 52.4
Falsely not indicated s/h 8.7 12.5 6.7 25.0 25.0 6.7 7.5 8.3 23.8
Noncompliance 2.9 25.0     20.0 17.0 25.0 9.5
Adverse drug event 8.7 25.0 6.7 12.5 25.0 6.7 11.3 25.0 4.8
Falsely discontinued 1.4   6.7    6.7 3.8   
Contraindication       26.7   8.3 9.5
Avoidance of polypharmacy        3.8   
  1. Summation does not add up to 100% due to rounding error.
  2. Anti-HT: antihypertensive medication (RAAS-inhibitor or thiazide or calcium channel blocker or β-blocker).
  3. Metformin: metformin in diabetes mellitus type 2 patients.
  4. HF = heart failure.
  5. βB: beta adrenoceptor blocker.
  6. RAAS-I: inhibitor of the renin-angiotensin-aldosterone system.
  7. AldoA: aldosterone antagonist.
  8. AF = atrial fibrillation.
  9. OAK: oral anticoagulation.
  10. CVD = cardiovascular disease.
  11. PAI: platelet aggregation inhibitor (acetylsalicylic acid or clopidogrel/prasugrel).
  12. MCI = myocardial infarction.